Formulation and Evaluation of Oral dispersible Tablet of Paroxetine Hydrochloride

Authors

  • Ria Shah SAL Institute of Pharmacy, Gujarat, India
  • Disha Patel SAL Institute of Pharmacy, Gujarat, India
  • Dhruvanshi Kothari SAL Institute of Pharmacy, Gujarat, India
  • Hetvi Shah SAL Institute of Pharmacy, Gujarat, India
  • Aishwarya Chavda SAL Institute of Pharmacy, Gujarat, India
  • Manan Patel Department of Pharmaceutics, SAL Institute of Pharmacy, Gujarat, India https://orcid.org/0000-0001-6978-960X
  • Riddhi Trivedi Head of Department of Pharmaceutics, SAL Institute of Pharmacy, Gujarat, India https://orcid.org/0000-0003-4385-6231

Abstract

Orodispersible tablets (ODTs) is one such novel approach which helps to increase user acceptance by virtue of rapid disintegration, self-administration without water or chewing. ODTs are solid unit dosage forms like the conventional tablets containing super disintegrants, which help them to disintegrate and/or disperse rapidly in the mouth within few seconds. The orodispersible tablet of Paroxetine hydrochloride was prepared by using direct compression method and the tablet were formulated using various concentration of Kyron T-314 as disintegrating agent, PVP K-30 as binder, F melt Type C as diluent, Sodium Saccharin as sweetening agent, talc as lubricant and Aerosil as glidant respectively. All the batches were prepared according to Factorial design. The prepared tablets were evaluated for various parameters like hardness, dissolution, friability, weight variation, disintegration time. Batch F5 was found to be the best batch as the disintegration time is minimum (26seconds) and better drug release profile. Orodispersible tablets of Paroxetine Hydrochloride were successfully formulated by which first pass metabolism could be avoided and faster onset of action could be achieved.

Keywords:

Paroxetine hydrochloride, orodispersible tablets, first pass metabolism, bioavailability, post menopause syndrome

DOI

https://doi.org/10.22270/jddt.v11i4.4921

Author Biographies

Ria Shah, SAL Institute of Pharmacy, Gujarat, India

Undergraduate Student, B.Pharm, SAL Institute of Pharmacy, Gujarat, India

Disha Patel, SAL Institute of Pharmacy, Gujarat, India

Undergraduate Student, B.Pharm, SAL Institute of Pharmacy, Gujarat, India

Dhruvanshi Kothari, SAL Institute of Pharmacy, Gujarat, India

Undergraduate Student, B.Pharm, SAL Institute of Pharmacy, Gujarat, India

Hetvi Shah, SAL Institute of Pharmacy, Gujarat, India

Undergraduate Student, B.Pharm, SAL Institute of Pharmacy, Gujarat, India

Aishwarya Chavda, SAL Institute of Pharmacy, Gujarat, India

Undergraduate Student, B.Pharm, SAL Institute of Pharmacy, Gujarat, India

Manan Patel, Department of Pharmaceutics, SAL Institute of Pharmacy, Gujarat, India

Assistant Professor, Department of Pharmaceutics, SAL Institute of Pharmacy, Gujarat, India

Riddhi Trivedi, Head of Department of Pharmaceutics, SAL Institute of Pharmacy, Gujarat, India

Professor, Head of Department of Pharmaceutics, SAL Institute of Pharmacy, Gujarat, India

References

Takahashi TA, Johnson KM, "Menopause". The Medical Clinics of North America, 2015; 99 (3):521-34. https://doi.org/10.1016/j.mcna.2015.01.006

Natalie Silver (2021, April 25). What Health Changes Should You Expect Postmenopause?Healthline.com https://www.healthline.com/health/menopause/postmenopausal-health

Koothirezhi, R. (2021, April 30). Postmenopausal syndrome. Statpearl.Com. https://www.statpearls.com/articlelibrary/viewarticle/27522/

Rewar S, Singh CJ, Bansal BK, Pareek R, Sharma AK., Oral Dispersible Tablets: an Overview; Development, Technologies and Evaluation, International Journal of Research and Development in Pharmacy and Life Sciences, 2014; 3(6):1245-1257

Bayrak Z and Tas C, "Formulation of Zolmitriptan sublingual tablet prepared by direct compression with different polymers: in vitro and in vivo. Eur J of Biopharm, 2011; 78(3):499-505 https://doi.org/10.1016/j.ejpb.2011.02.014

Amrutha JV, Cotton Cellulose, Pre and Post Compression Studies of Tablets, Inorganic Chemistry: An Indian Journal, 2016; 11(4):101

Amidon GE, Mudie DM, (2021, May 15), Developing Solid Oral Dosage Forms, 2017 https://www.sciencedirect.com/

Arunachalam A, Mazumder A, The outcome of formulation and in vitro release studies of levothyroxine sodium tablets, Asian Journal of Pharmaceutical Science & Technology, 2011; 1(1):33-39

Alagumanivasagam G, Srinivasu C, Formulation and evaluation of atorvastatin calcium film coated tablets, International Journal of Pharmaceuticals and Health care Research, 2018; 6(3):55-66

Chindhu PN, Formulation and Evaluation of Orodispersible Tablets of Metoclopramide Hydrochloride, the tamilnadu Dr. M.G.R. Medical University, Chennai, 2012

Gaur K, Sharma CS, Formulation and Characterization of Fast Disintegrating Tablet of Aceclofenac by using Sublimation Method, International Journal of Pharmaceutical Sciences and Drug Research, 2011; 3(1):19-22

Published

15-07-2021
Statistics
Abstract Display: 804
PDF Downloads: 595
PDF Downloads: 154

How to Cite

1.
Shah R, Patel D, Kothari D, Shah H, Chavda A, Patel M, et al. Formulation and Evaluation of Oral dispersible Tablet of Paroxetine Hydrochloride. J. Drug Delivery Ther. [Internet]. 2021 Jul. 15 [cited 2025 Jan. 21];11(4):41-7. Available from: https://www.jddtonline.info/index.php/jddt/article/view/4921

How to Cite

1.
Shah R, Patel D, Kothari D, Shah H, Chavda A, Patel M, et al. Formulation and Evaluation of Oral dispersible Tablet of Paroxetine Hydrochloride. J. Drug Delivery Ther. [Internet]. 2021 Jul. 15 [cited 2025 Jan. 21];11(4):41-7. Available from: https://www.jddtonline.info/index.php/jddt/article/view/4921